Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Active
Yes
Status
Posted
Published Date
November 22nd, 2023
Close Date
November 16th, 2026
Award Ceiling
$350,000.00
Opportunity No.
PAR-24-068

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health is offering a grant opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)". This grant aims to support research on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The grant will focus on reducing prenatal alcohol exposure and the incidence of FASD through prevention approaches, as well as developing interventions for FASD. The grant will be awarded through the Exploratory/Developmental Phased Award (R61/R33) mechanism, with the R61 phase supporting pilot studies and hypothesis development, and the R33 phase allowing for expanded research testing. Priority will be given to applications with clinical trials. Other eligible applicants include various institutions, organizations, and agencies. The grant has a closing date of November 16, 2026, and an award ceiling of $350,000. For more information and to apply, visit the following link: Grant Information.

Description

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and the incidence of FASD and that (2) interventions for FASD. These objectives will be accomplished with the Exploratory/Developmental Phased Award (R61/R33) mechanism, clinical trial optional. The R61 phase will support pilot studies or secondary data analysis for hypothesis development and feasibility, and research testing the hypotheses can be expanded in the R33 phase. The transition to the R33 phase will be determined by NIAAA program staff after evaluation of the achievement of specific milestones set for the R61 phase. Highest priority will be given to applications with clinical trials. Applicants interested in planning clinical trials or adding to current projects may also consider NOFO (TEMP-23832, the R34 option).

Contact Information

Attachments
0 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)". This grant aims to support research on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The goal is to reduce prenatal alcohol exposure and the incidence of FASD, as well as develop interventions for FASD. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The funding amount for this grant has a ceiling of $450,000. For more information and to apply, please visit the following link: [Additional Information](http://grants.nih.gov/grants/guide/pa-files/PAR-24-067.html).
Supporting Fetal Alcohol Spectrum Disorders Screening and Intervention
Health Resources and Services Administration
The Health Resources and Services Administration is offering a federal grant for the Supporting Fetal Alcohol Spectrum Disorders Screening and Intervention program. This program aims to reduce alcohol use during pregnancy and improve outcomes for children with FASD nationwide, particularly in communities with high rates of binge drinking during pregnancy. The program focuses on educating Primary Care Providers (PCPs) and increasing the use of screening, intervention, and referral processes for high-risk pregnancies. It also aims to enhance PCPs' knowledge of the risks of drinking alcohol during pregnancy and promote recommended screenings, interventions, and referral approaches. Additionally, PCPs who provide healthcare to children and adolescents will develop skills to identify and manage FASD, with an emphasis on effective communication with families. The program plans to engage a minimum of 80 practices over 5 years, with a focus on rural areas and medically underserved communities. The grant has an award ceiling of $950,000 and does not require cost sharing or matching. All domestic public or private entities, including nonprofits, for-profit organizations, small businesses, and various government entities, are eligible to apply. For more information, visit the grant opportunity page: [link](https://grants.hrsa.gov/2010/Web2External/Interface/FundingCycle/ExternalView.aspx?fCycleID=1c0ca566-a80b-490b-a9e8-1c71ef744b54). For inquiries, contact M. Sonsy Fermin at (301)443-1702 or email wellwomancare@hrsa.gov.
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)". This grant aims to address the treatment gap for individuals with alcohol use disorder (AUD) by focusing on five major areas of emphasis. These areas include increasing access to treatment for AUD, making treatment more appealing, examining cost structures and insurance systems, conducting studies on dissemination and implementation of evidence-based approaches, and reducing health disparities for health disparity populations. The grant has a funding ceiling of $450,000 and does not require cost sharing or matching. The deadline for applications is September 7, 2026. For more information and to apply, visit the following link: [Alcohol Treatment, Pharmacotherapy, and Recovery Research Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-249.html).